Ultrasound- and microspheres-enhanced thrombolysis for stroke treatment: State of the art

Current Cardiology Reports

Volumn 12, Issue 1, 2010, Pages 34-41

  Balucani, Clotilde ^a   Alexandrov, Andrei V ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Outcome; Reperfusion; Stroke; Thrombolysis; Ultrasound

Indexed keywords

ALTEPLASE; MICROSPHERE;

CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC ACCURACY; DOPPLER ECHOGRAPHY; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HUMAN; NONHUMAN; PATIENT SAFETY; REVIEW; STROKE; SYSTEMIC THERAPY; THERAPY EFFECT; TREATMENT OUTCOME; ULTRASOUND THERAPY;

ACUTE DISEASE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; MICROSPHERES; MYOCARDIAL REPERFUSION; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77249167877     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-009-0082-0     Document Type: Review

References (62)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group [no authors listed]. N Engl J Med 1995, 333:1581-1587.
2. W Hacke M Kaste E Bluhmki, et al. 2008 Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke N Engl J Med 359 1317 1329 10.1056/NEJMoa0804656 1:CAS:528:DC%2BD1cXhtFGqu77E 18815396 This is the second positive phase 3 trial of intravenous rt-PA. It showed that intravenous rt-PA between 3 to 4.5 hours after symptom onset improves clinical outcomes in acute ischemic stroke at a small risk of sICH. Time window expansion for rt-PA is now endorsed by the US and European guidelines.
3. GJ Del Zoppo JL Saver EC Jauch HP Adams Jr 2009 Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association Stroke 40 2945 2948 10.1161/STROKEAHA. 109.192535 19478221
4. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee 2008 Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 Cerebrovasc Dis 25 457 507 10.1159/000131083 (Pubitemid 351754643)
5. A Furlan R Higashida L Wechsler, et al. 1999 Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism JAMA 282 2003 2011 10.1001/jama.282.21.2003 1:CAS:528:DC%2BD3cXhtFek 10591382
6. WS Smith G Sung S Starkman, et al. 2005 Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial Stroke 36 1432 1438 10.1161/01.STR.0000171066.25248.1d 15961709 (Pubitemid 40967507)
7. WS Smith 2006 Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I AJNR Am J Neuroradiol 27 1177 1182 1:STN:280:DC%2BD28zmtVajtA%3D%3D 16775259
8. A Bose H Henkes K Alfke, et al. 2008 The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism AJNR Am J Neuroradiol. 29 1409 1413 10.3174/ajnr.A1110 1:STN:280:DC%2BD1crhs1Giug%3D%3D 18499798
9. AV Alexandrov AM Demchuk RA Felberg, et al. 2000 High rate of complete recanalization and dramatic clinical recovery during TPA infusion when continuously monitored by 2 MHz transcranial Doppler monitoring Stroke 31 610 614 1:CAS:528:DC%2BD3cXitVCgtLc%3D 10700493
10. AV Alexandrov WS Burgin AM Demchuk, et al. 2001 Speed of intracranial clot lysis with intravenous TPA therapy: sonographic classification and short term improvement Circulation 103 2897 2902 1:CAS:528:DC%2BD3MXltlyjtr0%3D 11413077
11. AV Alexandrov CA Molina JC Grotta, et al. 2004 Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke N Engl J Med 351 2170 2178 10.1056/NEJMoa041175 1:CAS:528:DC%2BD2cXhtVSqtLzO 15548777 (Pubitemid 39507629)
12. JH Rha JL Saver 2007 The impact of recanalization on ischemic stroke outcome: a meta-analysis Stroke 38 967 973 10.1161/01.STR.0000258112.14918.24 17272772 (Pubitemid 46568460)
13. DA De Silva JN Fink S Christensen, et al. 2009 Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET). Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators Stroke 40 2872 2874 10.1161/STROKEAHA.108.543595 19478228 The EPITHET was a prospective, randomized, placebo-controlled trial of intravenous tissue plasminogen activator in the 3- to 6-hour window. It showed that reperfusion and recanalization with intravenous tissue plasminogen activator were strongly correlated. Reperfusion was associated with improved clinical outcome independent of whether recanalization occurred.
14. G Tsivgoulis VK Sharma AY Lao, et al. 2007 Validation of transcranial Doppler with computed tomography angiography in acute cerebral ischemia Stroke 38 1245 1249 10.1161/01.STR.0000259712.64772.85 17332465 (Pubitemid 351664275)
15. AV Alexandrov JC Grotta 2002 Arterial re-occlusion in stroke patients treated with intravenous tissue plasminogen activator Neurology 59 862 867 10.1001/archneur.59.5.862 1:CAS:528:DC%2BD38XntVynsLY%3D 12297567
16. AV Alexandrov VK Sharma AY Lao, et al. 2007 Reversed Robin Hood syndrome in acute ischemic stroke patients Stroke 38 3045 3048 10.1161/STROKEAHA.107. 482810 17916768 This descriptive study suggested the possibility to detect and quantify the cerebral steal phenomenon in real time by TCD with important therapeutic implications: confirming the steal as the cause of neurologic worsening, rRHS may identify a target group for testing blood pressure augmentation and noninvasive ventilatory correction in stroke patients. (Pubitemid 350035701)
17. CW Francis 2001 Ultrasound-enhanced thrombolysis Echocardiography 18 239 246 10.1046/j.1540-8175.2001.00239.x 1:STN:280:DC%2BD3Mvitlansw%3D%3D 11322907
18. Kimura M, Iijima S. Kobayashi K, Furuhata H: Evaluation of the thrombolytic effect of tissue-type plasminogen activator with ultrasound irradiation: in vitro experiment involving assay of the fibrin degradation products from the clot. Biol Pharm Bull 1994, 17:126-130.
19. R Trubestein HR Bernard F Etzel, et al. 1976 Thrombolysis by ultrasound Clin Sci Mol Med 51 697 698
20. M Akiyama T Ishibashi T Yamada H Furuhata 1998 Low-frequency ultrasound penetrates the cranium and enhances thrombolysis in vitro Neurosurgery 43 828 832 10.1097/00006123-199810000-00062 1:STN:280:DyaK1cvjslOjsg%3D%3D 9766310 (Pubitemid 28436329)
21. V Suchkova FN Siddiqi EL Carstensen, et al. 1998 Enhancement of fibrinolysis with 40-kHz ultrasound Circulation 98 1030 1035 1:STN:280:DyaK1cvgslGnsA%3D%3D 9737524
22. S Behrens M Daffertshoffer D Spiegel M Hennerici 1999 Low-frequency, low-intensity ultrasound accelerates thrombolysis through the skull Ultrasound Med Biol 25 269 273 10.1016/S0301-5629(98)00158-6 1:STN:280:DyaK1M3lt1Sltg%3D%3D 10320316 (Pubitemid 29133234)
23. JF Polak 2004 Ultrasound energy and the dissolution of thrombus N Engl J Med 351 2154 2155 10.1056/NEJMp048249 1:CAS:528:DC%2BD2cXhtVSqtL7I 15548774 (Pubitemid 39507626)
24. CW Francis A Blinc S Lee C Cox 1995 Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots Ultrasound Med Biol 21 419 424 10.1016/0301-5629(94)00119-X 1:STN:280:DyaK2MzntlSmsA%3D%3D 7645133
25. DV Sakharov M Barrertt-Bergshoeff RT Hekkenberg DC Rijken 1999 Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro Thromb Haemost 81 605 612 1:CAS:528:DyaK1MXisFSlsb4%3D 10235448
26. P Cintas AP Le Traon V Larrue 2002 High rate of recanalization of middle cerebral artery occlusion during 2-MHz transcranial color-coded Doppler continuous monitoring without thrombolytic drug Stroke 33 626 628 10.1161/hs0202.103073 11823681 (Pubitemid 34123418)
27. A Blinc CW Francis JL Trudnowski EL Carstensen 1993 Characterization of ultrasound-potentiated fibrinolysis in vitro Blood 81 2636 2643 1:CAS:528:DyaK3sXks1yrurc%3D 8490172
28. J Eggers B Koch K Meyer, et al. 2003 Effect of ultrasound on thrombolysis of middle cerebral artery occlusion Ann Neurol 53 797 800 10.1002/ana.10590 12783427 (Pubitemid 36622518)
29. M Daffertshofer A Gass P Ringleb, et al. 2005 Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial Stroke 36 1441 1446 10.1161/01.STR.0000170707.86793.1a 15947262 (Pubitemid 40967509)
30. M Daffertshofer Z Huang M Fatar, et al. 2004 Efficacy of sonothrombolysis in a rat model of embolic ischemic stroke Neurosci Lett 361 115 119 10.1016/j.neulet.2004.02.003 1:CAS:528:DC%2BD2cXjvVGltb4%3D 15135907 (Pubitemid 38609230)
31. M Reinhard A Hetzel S Kruger, et al. 2006 Blood-brain barrier disruption by low-frequency ultrasound Stroke 37 1546 1548 10.1161/01.STR.0000221813.27519. 0b 16645131 (Pubitemid 44305740)
32. G Tsivgoulis CA Molina J Eggers, et al. 2008 Safety and efficacy of ultrasound-enhanced thrombolysis: a meta-analysis of randomized and non-randomized studies Stroke 39 593 594 This meta-analysis of six randomized and three nonrandomized clinical studies of sonothrombolysis showed that any diagnostic ultrasound monitoring can at least double the chance of early complete arterial recanalization at no increase in the risk of symptomatic intracerebral hemorrhage.
33. AM Demchuk WS Burgin I Christou, et al. 2001 Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery and mortality in intravenous TPA treated patients Stroke 32 89 93 1:CAS:528:DC%2BD3MXhtFKhsro%3D 11136920
34. A Alexandrov M Schafer 2008 Operator-independent device for sonothrombolysis Cerebrovasc Dis 26 Suppl 1 6
35. A Alonso 2007 Della Martina A, Stroick M, et al.: Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound Stroke 38 1508 1514 10.1161/STROKEAHA.106.471391 1:CAS:528:DC%2BD2sXktlSmsro%3D 17379828 (Pubitemid 46684166)
36. F Vignon B Arnal W Shi, et al. 2008 Mapping the acoustical transparency of the skull Cerebrovasc Dis 26 Suppl 1 13
37. M Tanter O Couture M Fink 2008 Time reversal of acoustic waves in the nonlinear regime: basic physics and application to ultrasound contrast imaging J Acoust Soc Am 123 3830 10.1121/1.2935608
38. Hoelscher T, Tu E, Ackley D: Development of an acoustically active TPA drug carrier: experiences with a first prototype. Cerebrovasc Dis 2008, 26(Suppl1):15-16.
39. S Harnof G Schiff A Hananel, et al. 2008 Trans-skull clot lysis-proof of concept Cerebrovas Dis 26 Suppl 1 12
40. T Tomsick J Broderick J Carrozella, et al. 2008 Revascularization results in the Interventional Management of Stroke II trial AJNR Am J Neuroradiol 29 582 587 10.3174/ajnr.A0843 1:STN:280:DC%2BD1c3gtVWlsQ%3D%3D 18337393
41. BR Mahon GM Nesbit SL Barnwell, et al. 2003 North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke AJNR Am J Neuroradiol 24 534 538 12637311
42. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the interventional management of stroke study. The IMS Study Investigators [no authors listed]. Stroke 2004, 35:904-912.
43. The interventional management of stroke (IMS) II study 2007 IMS II Trial Investigators [no authors listed] Stroke 38 2127 2135 10.1161/STROKEAHA.107. 483131 (Pubitemid 47012279)
44. R Gramiak PM Shah 1968 Echocardiography of the aortic root Invest Radiol 3 356 366 10.1097/00004424-196809000-00011 1:STN:280:DyaF1M%2FjtV2rsw%3D%3D 5688346
45. K Ferrara R Pollard M Borden 2007 Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery Annu Rev Biomed Eng 9 415 447 10.1146/annurev.bioeng.8.061505.095852 1:CAS:528:DC%2BD2sXhtVehtLfN 17651012 (Pubitemid 350246663)
46. S Meairs 2008 Contrast-enhanced ultrasound perfusion imaging in acute stroke patients Eur Neurol 59 17 26 10.1159/000114456 18382109
47. H Bleeker K Shung J Barnhart 1990 On the application of ultrasonic contrast agents for blood flowmetry and assessment of cardiac perfusion J Ultrasound Med 9 461 471 1:STN:280:DyaK3czns1Cjtw%3D%3D 2204718
48. BA Kaufmann JR Lindner 2007 Molecular imaging with targeted contrast ultrasound Curr Opin Biotechnol 18 11 16 10.1016/j.copbio.2007.01.004 1:CAS:528:DC%2BD2sXhvVyis70%3D 17241779 (Pubitemid 46237740)
49. M Schneider 2008 Molecular imaging and ultrasound-assisted drug delivery J Endourol 22 795 801 10.1089/end.2007.9821 18366315 (Pubitemid 351550759)
50. CA Molina M Ribo M Rubiera, et al. 2006 Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator Stroke 37 425 429 10.1161/01.STR.0000199064.94588.39 1:CAS:528:DC%2BD28XlvVCmsw%3D%3D 16373632 (Pubitemid 43731999)
51. WC Culp TR Porter J Lowery, et al. 2004 Intracranial clot lysis with intravenous microbubbles and transcranial ultrasound in swine Stroke 35 2407 2411 10.1161/01.STR.0000140890.86779.79 15322299 (Pubitemid 39311272)
52. EC Unger T Porter W Culp, et al. 2004 Therapeutic applications of lipid-coated microbubbles Adv Drug Deliv Rev 56 1291 1314 10.1016/j.addr.2003. 12.006 1:CAS:528:DC%2BD2cXjtl2ktrY%3D 15109770 (Pubitemid 38510475)
53. PA Dayton KE Morgan AL Klibanov, et al. 1999 Optical and acoustical observations of the effects of ultrasound on contrast agents IEEE Trans Ultrason Ferroelectr Freq Control 46 220 232 10.1109/58.741536 1:STN:280: DC%2BD1c%2FotFCntg%3D%3D 18238417
54. VK Sharma G Tsivgoulis AY Lao, et al. 2008 Quantification of microspheres (μS) appearance in brain vessels: implications for residual flow velocity measurements, dose calculations and potential drug delivery Stroke 39 1476 1481 10.1161/STROKEAHA.107.501593 18356549
55. F Xie JM Tsutsui J Lof, et al. 2005 Effectiveness of lipid microbubbles and ultrasound in declotting thrombosis Ultrasound Med Biol 31 979 985 10.1016/j.ultrasmedbio.2005.03.008 15972204 (Pubitemid 40828637)
56. M Fatar M Stroick M Griebe, et al. 2008 Effect of combined ultrasound and microbubbles treatment in an experimental model of cerebral ischemia Ultrasound Med Biol 34 1414 1420 10.1016/j.ultrasmedbio.2008.02.008 1:STN:280: DC%2BD1crktVakuw%3D%3D 18436368
57. AV Alexandrov R Strong AW Wojner-Alexandrov J Aronowski 2006 Low-power 2 MHz transcranial ultrasound reduces ischemic brain damage in rat Stroke 37 680 10.1161/01.STR.0000201891.41764.e5 (Pubitemid 43731948)
58. AV Alexandrov R Mikulik M Ribo, et al. 2008 A pilot randomized clinical safety study of thrombolysis augmentation with ultrasound-activated perflutren lipid microspheres Stroke 39 1464 1469 10.1161/STROKEAHA.107.505727 1:CAS:528:DC%2BD1cXkvVeitL4%3D 18356546
59. F Perren J Loulidi D Poglia, et al. 2007 Microbubble potentiated transcranial duplex ultrasound enhances IV thrombolysis in acute stroke Cerebrovasc Dis 25 219 223
60. V Larrue A Viguier C Arnaud, et al. 2007 Transcranial ultrasound combined with intravenous microbubbles and tissue plasminogen activator for acute ischemic stroke: a randomized controlled study Stroke 38 472
61. Ribo M, Molina CA, Alvarez B, et al.: Intra-arterial administration of microbubbles and continuous 2-MHz ultrasound insonation to enhance intra-arterial thrombolysis. J Neuroimaging 2009 Feb 13 (Epub ahead of print).
62. CA Molina AD Barreto G Tsivgoulis, et al. 2009 Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial Ann Neurol 66 28 38 10.1002/ana.21723 1:CAS:528:DC%2BD1MXhtFWju7bL 19670432 This randomized, multicenter, phase 2 trial of microsphere dose escalation with systemic thrombolysis showed that perflutren-lipid microspheres can be safely combined with systemic rt-PA and ultrasound at a dose of 1.4 mL, reporting a trend toward higher early recanalization and clinical recovery rates compared with standard intravenous tissue plasminogen activator therapy.